WO2005046695A1 - Injection vitamin b complex for treatment of non specific vaginitis (bacterial vaginitis) - Google Patents
Injection vitamin b complex for treatment of non specific vaginitis (bacterial vaginitis) Download PDFInfo
- Publication number
- WO2005046695A1 WO2005046695A1 PCT/KE2004/000008 KE2004000008W WO2005046695A1 WO 2005046695 A1 WO2005046695 A1 WO 2005046695A1 KE 2004000008 W KE2004000008 W KE 2004000008W WO 2005046695 A1 WO2005046695 A1 WO 2005046695A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- complex
- vaginitis
- injection
- vitamin
- yeast
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
Definitions
- Non specific vaginitis is the most common lower genital infection worldwide, It is associated with alteration of normal vaginal flora rather than infection caused by specific microorganism, The condition is characterized by a decreased concentration of lacto-bacillus, an increased numbers of gardneralla vaginalis and excessive yeast cells but no candidiasis. The condition remains to be very irritating and stressful to many women worldwide, Non- specific vaginitis present with severe vulva itching, profuse vaginal discharge and vaginal Ph >4,5. Medicaments that have been used for the condition include, Gential Viloet, Boric acid, Nystatia, clotrimazole, Butoconazole, miconazole, econazole and ketaconazole.
- the drugs preparations that have been used include vaginal pessaries, oral tablets and topical creams, Metrodazole has also been used to combat the increased gram- negative micro- organisms in the vagina.
- Niacinamide, D-panthenol Benzyl-Alcohol in water for injection Niacinamide, D-panthenol Benzyl-Alcohol in water for injection.
- the natural sources of the vitamin B complex B are:-
- vit B is whole grains, nuts, eggs, yeast, meats, milk, beans, peas, and sweet potatoes.
- Panthothenic acid - organ meats and whole grain cereals® 5.
- Vit B Complex which is an extract from yeast
- Vit B Complex was given to inhibit the production of yeast in the vagina. More than 30 patients with clinical presentation of B.V, have been treated using vitamin B complex.
- Non-Specific vaginities is yeast related problem rather than bacterial infection and that it is not an external problem but an internal problem in individual patient which is yet to be established.
- injection B complex relieves the symptoms of Non specific vaginitis though the specific B. vitamin involved is also yet to be established. I therefore believe that with more research on Inj. Vitamin B complex; a light is blinking for management of non- specific vaginitis at the end of the tunnel.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KE39803 | 2003-11-17 | ||
KEKE/P/2003/00398 | 2003-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005046695A1 true WO2005046695A1 (en) | 2005-05-26 |
Family
ID=34587753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KE2004/000008 WO2005046695A1 (en) | 2003-11-17 | 2004-02-18 | Injection vitamin b complex for treatment of non specific vaginitis (bacterial vaginitis) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005046695A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5821618A (en) * | 1981-07-31 | 1983-02-08 | Sankyo Co Ltd | Immunoregulator composed of vitamin b composition |
WO1998042188A1 (en) * | 1997-03-26 | 1998-10-01 | Meryl Squires | Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
-
2004
- 2004-02-18 WO PCT/KE2004/000008 patent/WO2005046695A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5821618A (en) * | 1981-07-31 | 1983-02-08 | Sankyo Co Ltd | Immunoregulator composed of vitamin b composition |
WO1998042188A1 (en) * | 1997-03-26 | 1998-10-01 | Meryl Squires | Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
Non-Patent Citations (1)
Title |
---|
FRIEDLANDER A. ET AL: "Lactobacillus acidophillus and vitamin B complex in te treatment of vaginal infection", PANMINERVA MEDICA, vol. 28, 1986, pages 51 - 53 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101175503B (en) | Composition and method for regulating and remaining vaginal flora and vaginal acidity be normal | |
US20030017207A1 (en) | Compositions and methods for treating vulvovaginitis and vaginosis | |
WO1999026636A1 (en) | Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof | |
EP3324938B1 (en) | Topical formulations and treatments | |
RU2327486C1 (en) | Immunomodulating, antiviral, antibacterial, antioxidating, membrane stabilising, anti-inflammatory, antitoxic medicinal agent for inflammatory-infectious diseases | |
Durfee et al. | Ineffectiveness of erythromycin for treatment of Haemophilus vaginalis-associated vaginitis: possible relationship to acidity of vaginal secretions | |
CN114588253A (en) | Pharmaceutical composition for repairing and preventing vaginal mucosa aging and preparation thereof | |
CN1879661B (en) | Use of nocardia rubra cell wall skeleton in preparation of medicine for resisting mycotic infection | |
SAREWITZ | Treatment of genitourinary moniliasis with orally administered nystatin | |
WO2005046695A1 (en) | Injection vitamin b complex for treatment of non specific vaginitis (bacterial vaginitis) | |
EP1051162B1 (en) | Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate | |
Brincker | Treatment of oral candidiasis in debilitated patients with miconazole—a new potent antifungal drug | |
WO2004016245A1 (en) | Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections | |
Sanz et al. | Randomized comparative trial of three regimens of itraconazole for treatment of vaginal mycoses | |
WO2014187185A1 (en) | Use of pharmaceutical composition in treating dermatitis and eczema | |
Wiest et al. | Short-term treatment of vaginal candidiasis with fenticonazole ovules: a three-dose schedule comparative trial | |
EP1712229B1 (en) | Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same | |
CN102652752A (en) | Drug composition for treating senile vaginitis and preparation method thereof | |
US7705011B2 (en) | Agent for treatment and prevention of endometriosos and uterine adenomyosis | |
Regidor et al. | Treatment and prevention of trichomoniasis, bacterial vaginosis and candidiasis with a new 7-day regime containing metronidazole and miconazole in a single vaginal pessary | |
US12109195B2 (en) | Compositions and methods for treatment of vaginal infections | |
Gummerus et al. | Miconazole in the Treatment of Vaginal Candidosis A Multicenter Study/Miconazol in der Behandlung der Candida‐Kolpitis Eine multizentrische Studie | |
CN103127490A (en) | Medicinal composition for treating vulvovaginal candidiasis | |
CN106580981A (en) | Pharmaceutical composition for treating gynecologic inflammations as well as preparation method and application thereof | |
Holmstrom | 11 A 33-Year-Old Woman with Multiple Visits for Vaginal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |